Product Information

DONEPEZIL HCL 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0420 per EA under NDC 16571077803. Its NADAC has been published 257 times since Dec 22, 2021.

FDA first approved this application on May 31, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DONEPEZIL HCL 5 MG TABLET

Donepezil Hydrochloride
$0.0420per EA

Strength

5 mg/1

NDC

16571077803

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DONEPEZIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090056

FDA Approved

5/31/2011

TE Code

AB

On Market Since

5/31/2011

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for DONEPEZIL HCL 5 MG TABLET has been published 257 times since Dec 22, 2021, and over the history we have for it it has declined 13.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0420 per EA
All-time high$0.0540 (Mar 16, 2022)
All-time low$0.0334 (May 22, 2024)
52-week high$0.0446
52-week low$0.0420
Median price$0.0446
Average price$0.0448
Largest weekly change+28.3% (Nov 22, 2023)
Weeks tracked257
Tracking sinceDec 22, 2021

Price History

1W

-2.6%

1M

-4.6%

3M

-3.5%

6M

-4.2%

1Y

-1.1%

3Y

+5.1%

5Y

N/A

All

-13.8%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DONEPEZIL HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DONEPEZIL HCL 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0420 per EA (NDC 16571077803), effective Nov 18, 2026.

How has the price of DONEPEZIL HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for DONEPEZIL HCL 5 MG TABLET has declined 13.8%. It has been tracked across 257 weekly CMS publications since Dec 22, 2021.

What are the highest and lowest recorded NADAC prices for DONEPEZIL HCL 5 MG TABLET?

Since Dec 22, 2021, the NADAC for DONEPEZIL HCL 5 MG TABLET has ranged from a low of $0.0334 (May 22, 2024) to a high of $0.0540 (Mar 16, 2022), with a median of $0.0446 per EA.

Are there cheaper alternatives to DONEPEZIL HCL 5 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DONEPEZIL HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DONEPEZIL HCL 5 MG TABLET?

DONEPEZIL HCL 5 MG TABLET (NDC 16571077803) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.